Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Protamine Sulfate Is a Potent Inhibitor of Human Papillomavirus InfectionIn VitroandIn Vivo

Antimicrobial Agents and Chemotherapy(2021)10.1128/aac.01513-21Source: DataRank Database

Protamine Sulfate Is a Potent Inhibitor of Human Papillomavirus InfectionIn VitroandIn Vivo is a research paper published in Antimicrobial Agents and Chemotherapy (2021). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

Linked data & code

cellosaurus gen uniprot nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.71)OA: hybridTopics (47)IDs (PubMed, PMC, OpenAlex)Annotations (5)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Amira Zine El Abidine,Ricardo A. Gómez-Martinez,Virginie Bondu,Rosa T. Sterk,Zurab Surviladze

Live enrichment

PubMed:34723633 PMC:PMC8765401 OpenAlex:https://openalex.org/W3209188761

HHS | National Institutes of Health

Grant: CA207368

HHS | National Institutes of Health

Grant: P30CA118100

HHS | National Institutes of Health

Grant: T32AI007538

NCI NIH HHS

Grant: R01 CA207368

National Institutes of Health

Grant: 5T32AI007538-13

Biology of Infectious Disease and Inflammation

National Institutes of Health

Grant: 3P30CA118100-18S1

University of New Mexico Cancer Center Support Grant

National Institutes of Health

Grant: 5R01CA207368-04

Mechanisms of Infection by Oncogenic HPVs

FWCI

0.71

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1128/aac.01513-21

publisherhttps://doi.org/10.1128/aac.01513-21

publisherhttps://journals.asm.org/doi/pdf/10.1128/AAC.01513-21

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34723633

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8765401

Fields of Study

Cervical Cancer and HPV ResearchCancer, Stress, Anesthesia, and Immune ResponseReproductive tract infections research0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsCell LineFemaleHumansMicePapillomaviridaePapillomavirus InfectionsProtaminesVirus Internalization

MeSH Terms

AnimalsCell LineFemaleHumansProtaminesPapillomaviridaePapillomavirus InfectionsMiceVirus Internalization

Keywords

Protamine sulfateHeparan sulfateVirusProtamineCervical cancerCell cultureHPV infectionDrugSexually transmitted diseaseTumorsWartsAntiviral AgentsMicrobicideIntraepithelial NeoplasmPapillomavirus InfectionsVirus InternalizationCell LineMiceAnimalsHumansFemaleProtaminesPapillomaviridae

Sustainable Development Goals

SDG 3: 3. Good health

Protamine Sulfate Is a Potent Inhibitor of Human Papillomavirus InfectionIn VitroandIn Vivo

FAIR Checklist

Authors (7)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)